Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1991-06-17
1993-06-08
Friedman, S. J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
514165, 514781, 514960, 514970, A61K 3160, A61K 4700
Patent
active
052179656
ABSTRACT:
The stability of compositions of choline salicylate-metal salicylate-carboxymethylcellulose is improved by the incorporation therein of microcrystalline cellulose. The microcrystalline cellulose is linked to the remainder of the composition by liquid bridges and is preferably present in an amount of about 2.5-25% by weight. The microcrystalline cellulose enhances the stability of the composition and thereby enhances solid dosage forms thereof such as tablets, capsules, suppositories and granules.
REFERENCES:
patent: 4067974 (1978-01-01), Sasmor
patent: 5043168 (1991-08-01), Patel
Chemical Abstracts 109(18):156086(n) Rowe.
Chemical Abstracts 106(24): 201635(s)-Vander Watt.
Oshlack Benjamin
Pedi, Jr. Frank C.
Zirlis Joseph V.
Criares T. J.
Euroceltique S.A.
Friedman S. J.
LandOfFree
Stabilized solid dosage forms of choline metal carboxymethylcell does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized solid dosage forms of choline metal carboxymethylcell, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized solid dosage forms of choline metal carboxymethylcell will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1934190